SCHEMBL25834806

SCHEMBL25834806

CCCCN1C(=O)CCC(N2Cc3c(N)cccc3C2=O)C1=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 8/20 0.54
IKZF3 Q9UKT9 4/20 0.54
DDB1 Q16531 3/20 0.54
TNF P01375 2/20 0.54
IL1B P01584 2/20 0.54
IKZF1 Q13422 2/20 0.54
BRD4 O60885 1/20 0.54
MAP1LC3B Q9GZQ8 1/20 0.42
CYP19A1 P11511 4/20 0.39
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
PABPC1 P11940 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HTT P42858 1/20 0.36
HDAC1 Q13547 2/20 0.35
HDAC6 Q9UBN7 1/20 0.35
HDAC3 O15379 1/20 0.35
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL19359329 0.99 CRBN (0.53) CRBNIKZF3DDB1TNFIL1B
SCHEMBL25834811 0.97 CRBN (0.53) CRBNIKZF3DDB1TNFIL1B
Hydrochloric Acid SCHEMBL19359321 0.96 CRBN (0.52) CRBNIKZF3DDB1TNFIL1B
SCHEMBL12072673 0.94 CRBN (0.56) CRBNIKZF3DDB1TNFIL1B
Hydrochloric Acid SCHEMBL19359338 0.93 CRBN (0.55) CRBNIKZF3DDB1TNFIL1B
SCHEMBL13985293 0.89 CRBN (0.58) CRBNIKZF3DDB1TNFIL1B
Hydrochloric Acid SCHEMBL19359328 0.88 CRBN (0.57) CRBNIKZF3DDB1TNFIL1B
SCHEMBL22940888 0.87 CRBN (0.49) CRBNIKZF3DDB1TNFIL1B
SCHEMBL13529737 0.85 CRBN (0.52) CRBNIKZF3DDB1TNFIL1B
SCHEMBL19370962 0.85 CRBN (0.38) CRBNIKZF3DDB1TNFIL1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230226035-A1 SMALL MOLECULES AGAINST CEREBLON TO ENHANCE EFFECTOR T CELL FUNCTION H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230226035-A1 SMALL MOLECULES AGAINST CEREBLON TO ENHANCE EFFECTOR T CELL FUNCTION CD4, CRBN, GZMB CRBN 2/4885IKZF3 274/4885DDB1 3336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.